|
- 2019
Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation TherapyKeywords: stereotactic body radiation therapy (SBRT), kidney cancer, primary lesion, tumor response, toxicity Abstract: To evaluate the safety and efficacy of stereotactic body radiation therapy for primary lesion of renal cell carcinoma with long-term and regular follow-up of tumor size and renal function
|